XML 48 R42.htm IDEA: XBRL DOCUMENT v3.24.3
Collaboration Agreements, License Agreement and Revenues - AstraZeneca U.S./RoW Agreement - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Accounts receivable from related parties $ 29,030     $ 29,030   $ 12,553
Related cost of goods sold $ 5,295   $ 4,243 $ 36,227 $ 13,441  
AstraZeneca U.S./RoW Agreement [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Cumulative catch-up net adjustment   $ 25,700        
Related accounts receivable   26,000        
Related accrued liabilities   11,500        
Related cost of goods sold   $ 21,100